day 1 agenda

Scientific Program
     Day -1: July (07, 2025)
 Meeting Hall - 1
Registrations Open (08:30-09:10)
Opening Ceremony (09:10-09:30)
Moderator:
Jennie R Lill, Genentech Inc., United States
Keynote Talks
Mohamed El-Far,
Mansoura University,
Egypt
09:30-10:00 Title: Photodynamic therapy of tumors by Lasers from our bench discovery to clinical applications: Future perspective of using it in combination with our novel naturally derived nanoformulations as advancement therapy of cancer
     
Thomas Boldicke,
Helmholtz Centre for Infection Research,
Germany
10:00-10:30 Title: The future of cancer immunotherapy with recombinant T-cells and recombinant antibodies
     
Hui Zhang & Hong Sun,
University of Nevada,
United States
10:30-11:00 Title: Regulation of Hematopoiesis by A Methylation-Phosphorylation Switch in PRC2/EZH2
     
Group Photo & Refreshment Break (11:00-11:20)
Scientific Session I
Morning Session:
SessionChairs
Thomas Boldicke, Helmholtz Centre for Infection Research, Germany
&

Maria J Nieto, Northwell Health Cancer Institute, United States
     
Jennie R Lill,
Genentech Inc.,
United States
11:20-11:40 Title: TEAD-targeting small molecules trigger a cofactor switch to modulate the Hippo pathway
     
Maria J Nieto,
Northwell Health Cancer Institute,
United States
11:40-12:00 Title: AL Amyloidosis: A review of the literature
     
James Boyt,
University of South Carolina,
United States
12:00-12:20 Title: Development of a liquid biopsy: evaluating aberrant glycosylation in secreted and membrane glycoproteins 
     
Fotios Mpekris,
University of Cyprus,
Cyprus
12:20-12:40 Title: Combination of two approaches to modify the tumor microenvironment and enhance the effectiveness of nano-immunotherapy
     
Kyle Cowan,
Children's Hospital of Eastern Ontario,
Canada
12:40-13:00 Title: APOBEC2: Its role in the pannexin 1-mediated inhibition of rhabdomyosarcoma progression and potential as a novel therapeutic target
     
(13:00-14:00) Lunch Break @ Restaurant 
Scientific Session II
Afternoon Session:
SessionChairs:
Kyle Cowan, Children's Hospital of Eastern Ontario, Canada
&
Anne-Catherine Prats,
INSERM/ University of Toulouse, France
     
Anne-Catherine Prats,
INSERM/ University of Toulouse,
France
14:00-14:20 Title: Translational control of lymphangiogenic growth factor expression by long lncRNAs
     
Navid Madani,
Dana-Farber Cancer Institute Harvard Medical School,
United States
14:20-14:40 Title: Roadblocks to Cancer Care in the Occupied Palestinian Territories
     
Esin Sevgi Dogan,
Manisa Celal Bayar University,
Turkey
14:40-15:00 Title: Knowledge, attitudes, and beliefs regarding skin cancer among health sciences students in Turkey: A cross-sectional study
     
Seront Emmanuel,
Cliniques universitaires Saint Luc,
Belgium
15:00-15:20 Title: Evolving Strategies in the Management of Metastatic Renal Cell Carcinoma: A Practical Guide for Clinicians
     
Ting-Ting Ma,
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University,
China
15:20-15:40 Title: Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang inhibits the progression of triple negative breast cancer though the activation inhibition of NF-κB triggered by CAFs-derived IL6
     
Xiaotian Chen,
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School,
China
15:40-16:00 Title: The role of sarcopenic obesity for the prediction of prognosis of patients with gastrointestinal cancer
     
Refreshment Break(16:00-16:10)
     
Valentin Lecomte,
University of Mons,
Belgium
16:10-16:30 Title: Exploration of the radiosensitising potential of functionalised iron oxide nanoparticles
     
Yuexi Guo,
Affiliated Hospital of North Sichuan Medical College,
China
16:30-16:50 Title: Correlation Between Fatty Pancreas Disease and Pancreatic Diseases, Perioperative Complications of Pancreatic Surgery
     
Tehreem Fatima,
University of Connecticut,
United States
16:50-17:10 Title: The Effects of Belinostat and Long-Term AsiDNA Treatment on Gene Expression in Glioblastoma
     
Pannel Discussions
Conference Hotel:
Hotel NH Danube City
Address: Wagramer Str. 21, 1220 Wien, Austria
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

day 2 agenda

Scientific Program
     Day -2: July (08, 2025)
 Meeting Hall - 3
Keynote Talks
Pier Paolo Claudio,
University of Mississippi Medical Center,
United States
09:00-09:30 Title: Functional precision medicine using cancer stem cells in the era of precision medicine
     
Jagadananda Ghosh,
Henry Ford Health System,
United States
09:30-10:00 Title: Mechanism of antiandrogenic therapy resistance in prostate cancer: novel role of Tribbles 2 driving neuroendocrine trans-differentiation
     
Fuad Fares,
University of Haifa,
Israel
10:00-10:30 Title: Development of New Strategies for the treatment of Cancer Using Natural Products
     
Refreshment Break (10:30-10:40)
     
Scientific Session III
SessionChairs

Shunfu Hu, Southern Illinois University, United States
&

Matilde Esther LLeonart, Vall d´Hebron Research Institute, Spain
     
Xinjian Lin,
Fujian Medical University,
China
10:40-11:00 Title: The AKT inhibitor AZD5363 elicits synthetic lethality in ARID1A-deficient gastric cancer cells via induction of pyroptosis
     
Vimolmas Tansathitaya,
College of Sports Science and Technology, Mahidol University,
Thailand
11:00-11:20 Title: Exercise Alters Microbiome Markers in Colorectal Cancer and Other Diseases
     
Matilde Esther LLeonart,
Vall d´Hebron Research Institute,
Spain
11:20-11:40 Title: New compounds targeting head and neck squamous cell carcinoma
     
Shunfu Hu,
Southern Illinois University,
United States
11:40-12:00 Title: Examining the Impact of Socio-demographic and Macro-environmental Factors on Cancer Mortality Rates in 2020 in Illinois, USA
     
Roland Hennes,
University Heidelberg,
Germany
12:00-12:20 Title: Primary Open Versus Closed Implantation Strategy for Totally Implantable Venous Access Ports
     
Jelena Sulic,
University of Mostar School of Medicine,
Bosnia and Herzegovina
12:20-12:40 Title: Correlation of Cytokine Profiles with Prostate-Specific Antigen and Disease Grade in Prostate Cancer
     
Annapaola Montagner,
University of Bologna - Mayo Clinic,
Italy
12:40-13:00 Title: The Notch signaling pathway: a promising druggable target for cancer treatment in combination with ICIs
     
(13:00-14:00) Lunch Break @ Restaurant 
     
SessionChairs:

Bat Chen R. Lubin, Eastern R&D center, Israel
&
Derek Roger Wilke, Dalhousie University, Canada
Poster presentations (14:00-14:40)
Scientific Session IV
     
Victoria Pham,
Genentech Inc.,
United States
14:40-15:00 Title: Discovering Entrectinib Resistance Mechanisms: A Longitudinal Phosphoproteomics and Chemicogenomics Approach
     
Bat Chen R. Lubin,
Eastern R&D center,
Israel
15:00-15:20 Title: Targeting EGFR using cyclic peptide for the treatment of EGFR overexpressed cancer
     
Shiwen Luo,
The First Affiliated Hospital of Nanchang University,
China
15:20-15:40 Title: LncRNA HOTTIP modulated by Hedgehog signaling drives colorectal cancer progression by promoting HUWE1-mediated ubiquitin-proteasome degradation of p53
     
Derek Roger Wilke,
Dalhousie University,
Canada
15:40-16:00 Title: The impact of National Holidays and early recurrence on outcomes in patients with squamous cell carcinoma of Head and Neck when treated by surgery and postoperative radiotherapy
     
Gulcin Ertas,
SBÜ Ankara Oncology Training and Researche Hospital,
Turkey
16:00-16:20 Title: General  features of metaplastic breast carcinoma  and case of bilateral squamous cell MBC   
     
Poster presentations (14:00-14:40)
     
Stephanie Langlois,
Children's Hospital of Eastern Ontario,
Canada
WCCRT-I Title: Targeting pannexin 1 to inhibit the malignant properties of human high-risk neuroblastoma: potential for drug repurposing
     
Nasreen Nakad,
University of Haifa,
Israel
WCCRT-II Title: The role of thyrostimulin and its subunits in cancer cell growth
     
Jianping Chen,
The university of Hong Kong,
Hong Kong
WCCRT-III Title: Efficacy of a medical food YH0618 in ameliorating chemotherapy-induced toxicity: a randomized clinical trial
     
Mario Seres,
Centre of Biosciences SAS,
Slovakia
WCCRT-IV Title: Effect of UV-C radiation on parental and multidrug-resistant sublines of murine leukemia cells L1210
     
Nasrin Fares Amer,
University of Haifa,
Israel
WCCRT-V Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer
     
Jakub Krepop,
Centre of Biosciences SAS,
Slovakia
WCCRT-VI Title: The role of epoxygenase of the arachidonic acid from P450 cytochrome family in proliferation of multidrug resistant leukemic cells
     
Lucia Pavlikova,
Centre of Biosciences SAS,
Slovakia
WCCRT-VII Title: TDo wolframin, P-glycoprotein, and GRP78/ BiP cooperate to alter the response of L1210 cells to endoplasmic reticulum stress or drug sensitivity?
     
Pannel Discussions
Closing Ceremony
Conference Hotel:
Hotel NH Danube City
Address: Wagramer Str. 21, 1220 Wien, Austria
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

Virtual Agenda

Scientific Program
 Day -2: July (08, 2025)
Virtual Presentations (Time Zone: CET)
     
Fangzhou Liu,
Nanjing Medical University,
China
09:00-09:20 Title: Transcription factor DDIT3 is a potential driver in pancreatic cancer
     
Lizhu Chen,
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital,
China
09:20-09:40 Title: Network pharmacology and molecular docking approach to elucidate the mechanisms of safflower, phellodendron, scutellaria baicalensis, coptis, and gardenia in hand–foot syndrome
     
Maocai Tang,
Chongqing University Cancer Hospital,
China
09:40-10:00 Title: The Comparative Study of Indocyanine Green and Carbon Nanoparticle Suspension Injection for Lymph Node Tracing in Laparoscopic Radical Gastrectomy for Gastric Cancer 
     
Byung-Chul Lee,
Genecast. co. ltd,
South Korea
10:00-10:20 Title: Clinical Validation of the Unparalleled Sensitivity of the Novel Allele-Discriminating Priming System Technology–Based EGFR Mutation Assay in NSCLC Patients
     
Eman Fares,
Arab Academic College for Education in Israel - Haifa,
Israel
10:20-10:40 Title: Inherited Cancer Risk: The Genetic Basis of Familial Cancer
     
Ewa Trybus,
Jan Kochanowski University of Kielce,
Poland
10:40-11:00 Title: Evaluation of anticancer acivity  of new generation antihistamine fexofenadine against HeLa and A545 line
     
Wojciech Trybus,
Jan Kochanowski University of Kielce,
Poland
11:00-11:20 Title: Alizarin induces a multidirectional mechanism of anti-cancer action in cervical cancer and prostate cancer cells
     
Anna Nikitjuka,
Latvian Institute of Organic Synthesis,
Latvia
11:20-11:40 Title: Benzoxaborinines as new anti-cancer agents for carbonic anhydrase inhibition
     
Nasrin Fares Amer,
University of Haifa,
Israel
11:40-12:00 Title: Natural Product from Asparagopsis taxiformis for Targeting Colorectal Cancer
     
Jekaterina Ivanova,
Latvian Institute of Organic Synthesis,
Latvia
12:00-12:20 Title: Inhibitors of selenoenzyme TrxR as anti-cancer agents – synthesis and biological evaluation
     
Aleksandrs Pustenko,
Latvian Institute of Organic Synthesis,
Latvia
12:20-12:40 Title: Thiazine 1,1-dioxide derivatives as potencial anticancer agents
     
Pinar Baydin,
Ankara University,
Turkey
12:40-13:00 Title: Role of Adhesion G Protein Coupled Receptors (aGPCRs) on Pericytes at Glioblastoma (GBM)- Pericyte Interaction
     
Nasreen Nakad,
University of Haifa,
Israel
13:00-13:20 Title: The role of thyrostimulin and its subunits in cancer cell growth
     
Liat Hamama,
Tel Aviv University,
Israel
13:20-13:40 Title: Dancing on the edge of the abyss Posttraumatic growth in men cancer survivors
     
Raimundo Fernandes de Araujo Júnior,
Universidade Federal do Rio Grande do Norte,
Brazil
13:40-14:00 Title: Extracellular Vesicles (EVs) from macrophages 1 as drugs carriers down-regulate the tumor progression and scape in murine colorectal cancer
     
Melinda Ildiko Mitranovici,
ESHRE,ISSVD,
Romania
14:00-14:20 Title: Cancer stemness: therapeutic and prognostic perspective in gynecology 
     
Mariana Zuliani Theodoro De Lima,
Mackenzie Presbyterian University/OncoAI,
Brazil
14:20-14:40 Title: Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer 
     
Anne Marinier,
Université de Montréal,
Canada
14:40-15:00 Title: Exploring ion chelators as a novel therapeutic modality in cancer
     
Chan Zhou,
University of Massachusetts Chan Medical School,
United States
15:00-15:20 Title: Flnc: Machine Learning Improves the Identification of Novel Long Noncoding RNAs from Stand-Alone RNA-Seq Data
     
Theodoros Karantanos,
Johns Hopkins University,
United States
15:20-15:40 Title: New insights into the biology and treatment of TP53 mutated myeloid neoplasms 
     
Veda N Giri,
Yale School of Medicine and Yale Cancer Center,
United States
15:40-16:00 Title: Patient-Centered Approaches in the Evolving World of Germline Testing for Prostate Cancer
     
Richard G Pestell,
Blumberg Institute,
United States
16:00-16:20 Title: Immune Oncology Therapy for Cancer: CCR5 Inhibitors, Bench to Bedside
     
Amosy M'Koma,
Vanderbilt University Medical Center,
United States
16:20-16:40 Title: Inflammatory Bowel Disease – Associated Colorectal Cancer Posed by Exogenous Free Hemoglobin Alpha Chain, An Unknown By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.
     
Christina M. Dieli-Conwright,
Harvard Medical School,
United States
16:40-17:00 Title: Getting to the heart of the matter: integration of exercise into cardio-oncology care
     
Pier Paolo Claudio,
University of Mississippi Medical Center,
United States
17:00-17:20 Title: Functional precision medicine using cancer stem cells in the era of precision medicine
     
Paula Eboli,
Cedars Sinai Medical Center,
United States
17:20-17:40 Title: Anaplastic pleomorphic xanthoastrocytoma with leptomeningeal dissemination presenting with cranial neuropathy in an adult patient: illustrative case
     
Heather A Jones,
Virginia Oncology Associates,
United States
17:40-18:00 Title: Deep Inspiration Breath Hold in a Community Setting
     
Closing Ceremony
Conference Hotel:
Hotel NH Danube City
Address: Wagramer Str. 21, 1220 Wien, Austria
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

Download